Cargando…
Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
BACKGROUND/AIMS: Real-world studies assessing the effectiveness and safety of sofosbuvir/velpatasvir (SOF/VEL) plus ribavirin (RBV) for Child-Pugh B/C hepatitis C virus (HCV)-related cirrhosis are limited. METHODS: We included 107 patients with Child-Pugh B/C HCV-related cirrhosis receiving SOF/VEL...
Autores principales: | Liu, Chen-Hua, Chen, Chi-Yi, Su, Wei-Wen, Liu, Chun-Jen, Lo, Ching-Chu, Huang, Ke-Jhang, Chen, Jyh-Jou, Tseng, Kuo-Chih, Chang, Chi-Yang, Peng, Cheng-Yuan, Shih, Yu-Lueng, Huang, Chia-Sheng, Kao, Wei-Yu, Yang, Sheng-Shun, Tsai, Ming-Chang, Wu, Jo-Hsuan, Chen, Po-Yueh, Su, Pei-Yuan, Hwang, Jow-Jyh, Fang, Yu-Jen, Lee, Pei-Lun, Tseng, Chi-Wei, Lee, Fu-Jen, Lai, Hsueh-Chou, Hsieh, Tsai-Yuan, Chang, Chun-Chao, Chang, Chung-Hsin, Huang, Yi-Jie, Kao, Jia-Horng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524072/ https://www.ncbi.nlm.nih.gov/pubmed/34255961 http://dx.doi.org/10.3350/cmh.2021.0155 |
Ejemplares similares
-
Limited effects of antibiotic prophylaxis in patients with Child–Pugh class A/B cirrhosis and upper gastrointestinal bleeding
por: Chang, Te-Sheng, et al.
Publicado: (2020) -
Child–Pugh Score and ABCG2-rs2231142 Genotype Independently Predict Survival in Advanced Hepatoma Patients Treated with Sorafenib
por: Huang, Po-Han, et al.
Publicado: (2022) -
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
por: Cheng, Pin-Nan, et al.
Publicado: (2021) -
Child Pugh and ALBI grade: past, present or future?
por: Rimini, Margherita, et al.
Publicado: (2020) -
Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7
por: Jiang, Jian-Qiang, et al.
Publicado: (2023)